Search Press releases Keywords From To 23 Nov 2023 Transparency notification Wellington Read More 16 Nov 2023 ‘Rheumacensus’ experts unite and call for essential psoriatic arthritis and axial spondyloarthritis care improvements Read More 11 Nov 2023 Post hoc analysis showed meaningful efficacy of certolizumab pegol for RA patients with high Rheumatoid Factor (RF) levels Read More 10 Nov 2023 UCB receives CHMP positive opinion for rozanolixizumab for treatment of adults with generalized myasthenia gravis in Europe Read More 10 Nov 2023 UCB Presents New Five-Year Data on BIMZELX[®]▼(bimekizumab) in Ankylosing Spondylitis at ACR Convergence 2023 Read More 9 Nov 2023 UCB successfully completes its offer to the public of fixed rate notes and decides to early terminate the subscription period Read More Pagination First page Previous page Previous … Page 2 Page 3 Page 4 Page 5 Current page 6 Page 7 Page 8 Page 9 Page 10 … Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe